| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849872 | American Heart Journal | 2008 | 7 Pages |
Abstract
These data emphasize the high vascular risk of RVD and suggest that angiotensin inhibitors may improve prognosis in this setting at the expense of acute renal toxicity. If the latter are selected in the management of RVD, renal function parameters should be assiduously followed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Daniel G. MD, PhD, Minh L. MSc, Muhammad PharmD, MA, MPH, Ping PhD, Sheldon W. MD, J. David MD, Amit X. MD, PhD,